Resources Contact Us Home
Monoclonal antibody to CD166 and method for production thereof

Image Number 2 for United States Patent #8003762.

CD166 is a cell adhesion molecule belonging to an immunoglobulin superfamily that is expressed in an excessive amount on the tumor surface. If an monoclonal antibody specifically binding to the CD166 is obtained, it becomes possible to suppress growth of tumor cells, detect the cells, and supply a therapeutic drug thereto specifically. However, because the CD166 proteins are very similar to each other among mammals, it was not possible to obtain an antibody to human CD166, by immunizing, for example, mice with the human CD166. The antibody was prepared by immunizing mice with a purified avian CD166 protein. The antibody was found to be adsorbed on human and mouse CD166 proteins in vitro as well as in vivo and to have an action to suppress tumor growth in mice.

  Recently Added Patents
Battery grid
Content display monitor
Methods to fabricate a photoactive substrate suitable for microfabrication
Coupling device having piercing member
Verification of computer-executable code generated from a model
Electric connection box
Wafer level package and fabrication method
  Randomly Featured Patents
Semiconductor device having spacer formed on semiconductor chip connected with wire
Burr ring with integral lead/catheter fixation device
Overlay mark for aligning different layers on a semiconductor wafer
Vehicle exterior
Process for producing 4,5-dihydroxy-2-imidazolidinones
Method of fabricating semiconductor device
Water-conserving urinal
Debugging an integrated circuit with an embedded processor
Pet litter
Halopyridyl derivatives of m-aminotetramisole as anthelmintics